logo image
search icon
Global Somatropin Market

Somatropin Market Size, Share & Trends Analysis Report By Applications (Chronic Renal Insufficiency, Growth Hormone Deficiency, Turners Syndrome, Prader-Willi Syndrome, Idiopathic Short Stature, and Noonan Syndrome), By Distribution Channel, Region And Segment Forecasts, 2024-2031

Report ID : 1111 | Published : 2024-04-01 | Pages: 180 | Format: PDF/EXCEL

The Somatropin Market is expected to grow at a 7.38 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • One factor driving the growing demand for somatropin is the increasing frequency of growth hormone deficiency diagnoses in both adults and children, while another is the improvement in medical diagnostic technology, which permits earlier and more precise identification of growth hormone deficiency.
  • Somatropin is in high demand due to the rising incidence of growth hormone diseases.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • Potential obstacles to the expansion of the somatropin market include the high expense of receiving treatment and the necessity of long-term medication.

somatropin

Growth hormone is a natural hormone secreted by the pituitary gland of the human body. It regulated various complex physiological processes of the body, which mainly include growth and metabolism. It plays a role in achieving normal growth in children and is also helps to regulate lipid, carbohydrate, and protein metabolism in all age groups (childhood & adulthood). The synthetic form of human growth hormone is known as somatropin. Until 1985, the growth hormone is obtained through extraction from cadaveric pituitary glands due to its side effect, it was discontinued, and the first synthetic growth hormone was approved by the U.S. Food Drug Administration in 1985 for the treatment of growth hormone deficiency. 

It is also approved for the treatment of chronic renal insufficiency, adult growth hormone deficiency, truners syndrome, Prader-Willi syndrome, idiopathic short stature, and Noonan syndrome. It is also an anti-aging therapy yet is not approved for this indication. Much synthetic human growth hormone is now available in the market, which includes Humatrope (Lilly), Nutropin (Genentech), Norditropin (Novo), Genotropin (Pfizer), and Saizen (Merck Serono). As of 2006, the recombinant version of somatropin was launched a ‘Omnitrope’ by Sandoz. Growing demand for somatropin, led by rising growth hormone deficiency cases and advancement in rDNA technology, has boosted the growth of the global somatropin market in the forecast period. Moreover, ongoing clinical trials of somatropin in various therapeutic areas further drive the development of the market. However, stringent regulatory process and complicated manufacturing process are the factors restrain the growth of the global somatropin market.

Market Segmentation

The global somatropin market is segmented on the basis of application, distribution channel, and geography. On the basis of application, the global somatropin market is further sub-segmented into chronic renal insufficiency, growth hormone deficiency, turners syndrome, Prader-Willi syndrome, idiopathic short stature, and Noonan syndrome. Growth hormone deficiency followed turners syndrome segment is expected to hold a significant share of the market due to an increase in the number of patients suffering from pituitary dysfunction and the effectivity of the somatropin to treat turners syndrome. Based on distribution channels, the global somatropin market is segmented into online pharmacy, hospital pharmacy and retail pharmacy. Hospital pharmacy is a major contributor in terms of revenue to the market as somatropin is available on prescription and increases the number of hospital visits.

At the regional level, the global Somatropin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of revenue, North America, followed by Europe, is a major contributor to the global somatropin market. This is partly because of increased government initiatives for cost-effective treatment and the rising number of pituitary dysfunction cases. Furthermore, a strong clinical pipeline and increasing research and drug development activities propel the growth of the market in these regions. The Asia Pacific is the third promising revenue contributor, which is expected to grow at a rapid pace in the upcoming year. Countries such as Japan, India, and China are significant contributors to this market and are identified as most lucrative for this market. Emerging and huge population base countries such as China and India offer tremendous market opportunities.

Competitive Landscape

Some of The Key Players in The Somatropin Market:

  • Eli Lilly & Company
  • Pfizer
  • Regeneron Pharmaceuticals
  • Sanofi-aventis
  • Mitsubishi Tanabe Pharma Corporation
  • Teva Pharmaceutical Industries
  • Astellas Pharma
  • Other Prominent Players

The Somatropin Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 7.38 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Applications, By Distribution Channel

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Sandoz, F. Hoffmann-La Roche AG, Pfizer, Eli Lilly and Company, Regeneron Pharmaceuticals, Novo Nordisk, Teva Pharmaceutical Industries, Merck co., and others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Somatropin Market Snapshot

Chapter 4. Global Somatropin Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Applications Estimates & Trend Analysis

5.1. By Applications & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Applications:

5.2.1. Chronic Renal Insufficiency

5.2.2. Growth Hormone Deficiency

5.2.3. Turners Syndrome

5.2.4. Prader-Willi Syndrome

5.2.5. Idiopathic Short Stature

5.2.6. Noona Syndrome

Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis

6.1. By Distribution Channel & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channel:

6.2.1. Hospital Pharmacy

6.2.2. Online Pharmacy

6.2.3. Retail Pharmacy

Chapter 7. Somatropin Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Somatropin Market revenue (US$ Million) estimates and forecasts By Applications, 2024-2031

7.1.2. North America Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.1.3. North America Somatropin Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

7.2. Europe

7.2.1. Europe Somatropin Market revenue (US$ Million) By Applications, 2024-2031

7.2.2. Europe Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.2.3. Europe Somatropin Market revenue (US$ Million) by country, 2024-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Somatropin Market revenue (US$ Million) By Applications, 2024-2031

7.3.2. Asia Pacific Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.3.3. Asia Pacific Somatropin Market revenue (US$ Million) by country, 2024-2031

7.4. Latin America

7.4.1. Latin America Somatropin Market revenue (US$ Million) By Applications, 2024-2031

7.4.2. Latin America Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.4.2. Latin America Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.4.3. Latin America Somatropin Market revenue (US$ Million) by country, (US$ Million) 2024-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Somatropin Market revenue (US$ Million) By Applications, 2024-2031

7.5.2. Middle East & Africa Somatropin Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2024-2031

7.5.3. Middle East & Africa Somatropin Market revenue (US$ Million) by country, 2024-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Eli Lilly & Company

8.2.2. Pfizer

8.2.3. Regeneron Pharmaceuticals

8.2.4. Sanofi-aventis

8.2.5. Mitsubishi Tanabe Pharma Corporation

8.2.6. Teva Pharmaceutical Industries

8.2.7. Astellas Pharma

8.2.8. Other Prominent Player with Pipeline Product Portfolio

Global Somatropin Market Segmentation

Global Somatropin Market Outlook By Application

  • Chronic Renal Insufficiency
  • Growth Hormone Deficiency
  • Turners Syndrome
  • Prader-Willi Syndrome
  • Idiopathic Short Stature
  • Noona Syndrome

somatropin

Global Somatropin Market Outlook By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Somatropin Market Outlook By Region

  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the Somatropin Market Growth?

Sandoz, F. Hoffmann-La Roche AG, Pfizer, Eli Lilly and Company, Regeneron Pharmaceuticals, Novo Nordisk, Teva Pharmaceutical Industries, Merck co., an

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach